SCHEMBL16599401

SCHEMBL16599401

CC(=O)Oc1ccccc1Cc1cc(C(=O)O)ccc1CO[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.45
ALDH1A1 P00352 5/20 0.43
TSHR P16473 3/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 1/20 0.40
HSD17B10 Q99714 2/20 0.40
RECQL P46063 1/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
PLA2G4A P47712 2/20 0.39
LTB4R Q15722 1/20 0.39
TTR P02766 1/20 0.38
MAPK1 P28482 1/20 0.38
ESR1 P03372 1/20 0.38
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
HMGB1 P09429 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17986280 0.77 TSHR (0.42) PTGS2ALDH1A1TSHRKDM4EGAA
SCHEMBL17986206 0.76 TMEM97 (0.43) ALDH1A1KDM4ERAB9ALMNARECQL
SCHEMBL678302 0.74 PTGS2 (0.62) PTGS2ALDH1A1TSHRKDM4ERAB9A
Aspirin SCHEMBL4160561 0.73 PTGS2 (0.53) PTGS2ALDH1A1TSHRKDM4ERAB9A
Aspirin SCHEMBL4160555 0.73 PTGS2 (0.53) PTGS2ALDH1A1TSHRKDM4ERAB9A
SCHEMBL4369867 0.72 RXRA (0.42) PTGS2ALDH1A1TTRHCAR3
SCHEMBL16599538 0.71 KDM4E (0.47) PTGS2ALDH1A1TSHRKDM4ELMNA
SCHEMBL2960866 0.69 TP53 (0.50) PTGS2ALDH1A1TSHRKDM4EMAPT
SCHEMBL27581275 0.69 KDM4E (0.52) PTGS2ALDH1A1TSHRKDM4ELMNA
SCHEMBL1982730 0.69 TSHR (0.63) ALDH1A1TSHRKDM4EGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3049386-B9 COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES UNIV KOELN (DE) 2020-11-18 EP disclosed
EP-3049386-B1 COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES UNIV KOELN (DE) 2020-07-22 EP disclosed
EP-3049386-A1 COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES Universität zu Köln (DE) 2016-08-03 EP disclosed
WO-2015044177-A1 COMPOUNDS USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES UNIVERSITÄT ZU KÖLN (DE) 2015-04-02 WO disclosed